Retroscreen Virology Senior Medical Director to speak at World Vaccine Congress USA 2015

The world’s leading research company in human viral challenge models, Retroscreen Virology, has announced one of its scientific and medical leadership team will be speaking at 2015 World Vaccine Congress in the USA. Dr Martin Johnson, Senior Medical Director at Retroscreen Virology, is going to be talking about the Retroscreen hVIVO human viral challenge model and how it can be …

Hybrid Delivery System Boosts DNA Vaccines Potential

Researchers at the University at Buffalo have developed a hybrid delivery system designed to fight cancer, HIV, flu, and other diseases Scientists from the University at Buffalo have created a novel hybrid system designed to deliver genetic antigens and elicit a strong immune response in patients, something DNA vaccines have so far failed to deliver. The hybrid, presented in the …

World Vaccine Congress Brochure Available

  The World Vaccine Congress Washington is now in its 15th year, and things look a little different to previous years. ‘So why the change?’ I hear you ask… In my previous role, we produced very focused agendas and ran two-day events specifically on that area. This would be as niche as talking only about foundations for deep water offshore …

What Lies Ahead for The Vaccine Industry?

  We’ve got to ‘fight our corner’ was the message from Novartis’ David McIntosh as he opened up the 2014 World Vaccine Congress Europe You opened the conference this morning with the claim that ‘we need to fight our corner’ in the vaccine industry. Is the vaccine industry in trouble?   The pharmaceutical industry is broadly divided into pharma products …

Michael Hanna Vaccinogen cancer vaccine prostate cancer

The Problem with Cancer Vaccines

  You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeaway message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught up with Michael Hanna, the founder of Vaccinogen and creator of autologous patient-specific tumour cell vaccine OncoVAX, to discuss why there have been so many high-profile cancer vaccine failures and how this has affected …

Building a Universal Flu Vaccine

  Developing a universal flu vaccine requires a two part strategy targeted at the surface of the flu virus and it’s unchanging core At Last week’s World Vaccine Congress 2014, Vaccine Nation sat down with professor Sarah Gilbertson from the University of Oxford to discuss her progress towards developing a universal vaccine. What strategy are you currently pursuing in search …

From Cedar and Peanut allergies to Cancer Vaccines and Immunotherapeutics: This is the future of DNA vaccine technology

One company stands on the brink of a revolution in vaccine technology that has the potential to change millions of lives with innovative DNA and RNA vaccines See the future of DNA vaccines: download the report For over 20 years the vaccines industry has pushed towards the goal of creating an effective DNA vaccine. But thus far the industry has …